老虎证券

BUZZ-Spruce Biosciences jumps as co moves toward FDA filing for rare childhood brain disorder drug

Reuters
02/18
BUZZ-<a href="https://laohu8.com/S/SPRB">Spruce Biosciences</a> jumps as co moves toward FDA filing for rare childhood brain disorder drug

** Shares of drug developer Spruce Biosciences SPRB.O rise 27% to $74 premarket

**  Co says its therapy targets Sanfilippo Syndrome Type B, a rare genetic disorder that causes progressive brain damage and loss of motor skills in children

** Co says FDA confirmed its existing clinical data could support an accelerated review of its experimental enzyme‑replacement therapy

**  Co says the treatment aims to replace a missing enzyme to slow or halt disease progression

**  Co says the drug has been tested in 22 patients over six years with a favorable safety profile

** SPRB says it expects to file its application in Q4 2026 after completing FDA manufacturing requirements

** Shares up ~177% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10